Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Lev Pavlovsky headshot

Lev

Pavlovsky

,

MD, PhD

Gray Faculty of Medical and Health Sciences
Tel Aviv University
Petah-Tikva
,
Israel
Councilor Since: January 1, 2023
IPC Councilor
Dr. Lev Pavlovsky is a Clinical Associate Professor of Dermatology at the Sackler Faculty of Medicine, Tel Aviv University. He earned his MD and PhD through the combined program at Ben-Gurion University of the Negev and completed his dermatology residency at Rabin Medical Center. He pursued advanced training in phototherapy and psoriasis at the Mount Sinai School of Medicine in New York, under the mentorship of Professor Mark Lebwohl.

Dr. Pavlovsky is the Director of the Psoriasis Treatment Unit and Outpatient Clinics in the Division of Dermatology at Rabin Medical Center in Petah Tikva, Israel. His clinical and research expertise lies in immunobiological therapies for psoriasis, and he has served as principal investigator in numerous international clinical trials in this field.

He is the Secretary of the Psoriasis Society of the Israel Society of Dermatology and Venereology (ISDV) and serves as Israel’s National Representative to the Skin Inflammation and Psoriasis International Network (SPIN) of the ISDV. Dr. Pavlovsky has authored over 60 scientific publications and book chapters and was a contributing author of the Israeli clinical guidelines for psoriasis treatment. His primary research interests include inflammatory skin diseases, with a focus on the immunopharmacology of psoriasis.
Last Updated:
07/11/2025

Areas of Interest

Immunobiological treatments; phototherapy; comorbidities such as psoriatic arthritis and inflammatory bowel disease (IBD) in patients with psoriasis

IPC Committees / Groups

Digital Health Working Group

Languages Spoken

English, Hebrew, Russian

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026